Prevalence of antibiotic resistance of Staphylococcus aureus in cystic fibrosis infection: a systematic review and meta-analysis
- PMID: 37211214
- DOI: 10.1016/j.jgar.2023.05.006
Prevalence of antibiotic resistance of Staphylococcus aureus in cystic fibrosis infection: a systematic review and meta-analysis
Abstract
Objectives: Cystic fibrosis (CF) is a hereditary recessive disease that affects the mucous clearance of the lungs and allows bacteria such as Staphylococcus aureus to settle in the lung and cause infection. This study examined the prevalence of antibiotic resistance of S. aureus in cystic fibrosis infection using a systematic review and meta-analysis.
Methods: A comprehensive and systematic search of related articles was conducted through the PubMed, Scopus, and Web of Science databases until March 2022. The weighted pooled resistance rate of antibiotics was analysed with Freeman-Tukey double arcsine transformation in the Stata software version 17.1 using the Metaprop command.
Results: In this meta-analysis, 25 studies were used based on criteria to evaluate the pattern of S. aureus resistance in CF. Vancomycin and teicoplanin were the most effective options for treatment of CF patients; the highest level of antibiotic resistance observed was to erythromycin and clindamycin.
Conclusion: High levels of resistance to most of the antibiotics studied was observed. The high levels of antibiotic resistance observed are worrisome and indicate the need to monitor antibiotic use.
Keywords: Antibiotic resistance; Cystic fibrosis; Meta analysis; Staphylococcus aureus; Vancomycin.
Copyright © 2023. Published by Elsevier Ltd.
Similar articles
-
A Middle East systematic review and meta-analysis of prevalence and antibiotic susceptibility pattern in MRSA Staphylococcus aureus isolated from patients with cystic fibrosis.J Health Popul Nutr. 2022 Jun 28;41(1):26. doi: 10.1186/s41043-022-00305-x. J Health Popul Nutr. 2022. PMID: 35765068 Free PMC article. Review.
-
Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis.Microb Pathog. 2022 Apr;165:105461. doi: 10.1016/j.micpath.2022.105461. Epub 2022 Feb 28. Microb Pathog. 2022. PMID: 35240288 Review.
-
Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.Int J Med Microbiol. 2018 Aug;308(6):631-639. doi: 10.1016/j.ijmm.2018.02.003. Epub 2018 Feb 24. Int J Med Microbiol. 2018. PMID: 29501453
-
Epidemiology of staphylococci species and their antimicrobial-resistance among patients with wound infection in Ethiopia: a systematic review and meta-analysis.J Glob Antimicrob Resist. 2022 Jun;29:483-498. doi: 10.1016/j.jgar.2021.10.025. Epub 2021 Nov 18. J Glob Antimicrob Resist. 2022. PMID: 34801740 Review.
-
Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.Microbiol Spectr. 2023 Feb 14;11(1):e0406122. doi: 10.1128/spectrum.04061-22. Epub 2022 Dec 15. Microbiol Spectr. 2023. PMID: 36519944 Free PMC article.
Cited by
-
New Pyrazolyl Thioureas Active against the Staphylococcus Genus.Pharmaceuticals (Basel). 2024 Mar 15;17(3):376. doi: 10.3390/ph17030376. Pharmaceuticals (Basel). 2024. PMID: 38543162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
